NEW YORK (GenomeWeb) – Ubiquitome has launched a crowdfunding campaign to support the development and validation of a molecular test for the Zika virus, with the goal of obtaining Emergency Use Authorization from the US Food and Drug Administration prior to the Olympic Games in Brazil this summer.
The New Zealand-based firm currently markets the Freedom4, a portable, battery-operated and iPhone-interfaced qPCR platform that can run four samples at a time.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
